← Leaderboards
Dwight C. German
Ut Southwestern Medical Center
$4,063,025
Attributed
$10,119,595
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,119,595 · 6
By mechanism
RF1$3,815,455 · 2
U01$2,999,418 · 1
R01$2,194,690 · 1
R56$714,524 · 1
R21$395,508 · 1
Top collaborators
- Richard B Dewey5 shared
- Ann Marie Stowe3 shared
- Rong Zhang3 shared
- David C Zhu3 shared
- Dean P. Jones2 shared
- Jason R Richardson2 shared
- Jeff G Mcdonald1 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Elan D Louis$34,798,515
- E Sherwood Brown$23,442,176
- Thomas J Wang$21,119,622
- Michael Kyba$19,625,267
- Yong Xu$17,937,421
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBloodSamplingParticipantBiological MarkersPlasmaGrantDisease ProgressionProteinsSerumBiologicalParkinson DiseaseDiagnosticSensitivity And SpecificityAntibodiesPeptoidsDiagnosisNational Institute Of Neurological Disorders And StrokeCellsPrevalenceProgramsPatient CareBase
Grant awards (13)
Environmental Exposome as a Driver in Alzheimerâs Disease$988,863
R01 · FY2025 · AG · contact PI
Environmental Exposome as a Driver of Race/Ethnicity Differences in Alzheimer's Disease$1,205,827
R01 · FY2024 · AG · contact PI
Diversity Supplement for Jenny Lutshumba$302,626
RF1 · FY2024 · AG
Biomarkers to Track Effective Interventions that Delay Dementia Onset in Participants of the "Risk Reduction for Alzheimer's Disease (rrAD)" Trial$2,297,829
RF1 · FY2023 · AG
Biomarkers to track effective interventions that delay dementia onset in participants of the "Risk Reduction for Alzheimer's Disease (rrAD)" trial$714,524
R56 · FY2021 · AG
Blood Biomarker for Alzheimer's Disease: Phospholipids$1,215,000
RF1 · FY2019 · AG · contact PI
Diagnostic and prognostic biomarkers for Parkinsons disease$474,763
U01 · FY2016 · NS · contact PI
Diagnostic and prognostic biomarkers for Parkinsons disease$515,427
U01 · FY2015 · NS · contact PI
Diagnostic and prognostic biomarkers for Parkinsons disease$686,042
U01 · FY2014 · NS · contact PI
Diagnostic and prognostic biomarkers for Parkinsons disease$677,884
U01 · FY2013 · NS · contact PI
Diagnostic and prognostic biomarkers for Parkinsons disease$645,302
U01 · FY2012 · NS · contact PI
Novel Method for Alzheimer's Disease Drug Discovery$165,145
R21 · FY2010 · AG · contact PI
Novel Method for Alzheimer's Disease Drug Discovery$230,363
R21 · FY2009 · AG · contact PI